PS Oluga Pushes for Stronger Novartis Partnership to Boost Cancer and NCD Care

Medical Services Principal Secretary Dr. Ouma Oluga has called for deeper collaboration between the Kenyan government and global pharmaceutical company Novartis to strengthen the fight against non-communicable diseases (NCDs) and improve cancer care services across the country.

Speaking during a meeting with representatives from Novartis, Dr. Oluga emphasized the growing burden of NCDs in Kenya and the urgent need for innovative partnerships to expand access to quality healthcare services. He noted that diseases such as cancer, diabetes, cardiovascular conditions, and chronic respiratory illnesses continue to place significant pressure on the country’s health system.

The Principal Secretary said strategic partnerships with the private sector will play a critical role in supporting Kenya’s efforts to improve disease prevention, early diagnosis, treatment, and long-term patient management. He stressed that collaboration should focus not only on access to medicines but also on strengthening healthcare infrastructure, training medical personnel, and enhancing research capabilities.

Dr. Oluga reiterated the government’s commitment to ensuring that all Kenyans have access to affordable and quality healthcare, in line with the Universal Health Coverage agenda. He noted that addressing the rising prevalence of non-communicable diseases requires a coordinated approach involving government agencies, development partners, healthcare providers, and the private sector.

The discussions also explored opportunities for expanding cancer care services, particularly in underserved areas where patients often face challenges accessing specialized treatment. Improved screening programs, community awareness initiatives, and investments in health technology were identified as key areas that could benefit from enhanced cooperation.

Novartis representatives expressed their commitment to supporting Kenya’s health priorities through initiatives aimed at improving patient outcomes and increasing access to care. The company has been involved in various global programs focused on expanding access to cancer and cardiovascular disease services in low- and middle-income countries.

Health experts have increasingly advocated for public-private partnerships as an effective way of addressing gaps in cancer treatment and NCD management, particularly in countries facing resource constraints. Such collaborations are seen as vital in strengthening health systems and ensuring sustainable healthcare delivery.